Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-02

Clinical Trial Update: Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery [Phase 2]

View source ↗

Summary

Phase 2 safety study evaluating Avastin (bevacizumab) as adjunctive therapy in pterygium surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Pterygium | Phase 2 | Status: COMPLETED | Results posted: 2016-09-02